Search Results - "Scott, Shane D."

Dose Conversion from Recombinant Human Erythropoietin to Darbepoetin alfa: Recommendations From Clinical Studies by Scott, Shane D.

“…Recombinant human erythropoietin (r‐HuEPO, epoetin alfa), is an established and effective treatment for anemia associated with both chronic kidney disease…”
Get full text

Drug-Induced QT-Interval Prolongation: Considerations for Clinicians by Li, Edward C., Esterly, John S., Pohl, Shaunte, Scott, Shane D., McBride, Brian F.

“…Drug‐induced proarrhythmia is a frequently encountered clinical problem and a leading cause for withdrawal or relabeling of prescription drugs. Suppression of…”
Get full text

Was Breast Conserving Surgery Underutilized for Early Stage Breast Cancer? Instrumental Variables Evidence for Stage II Patients from Iowa by Brooks, John M., Chrischilles, Elizabeth A., Scott, Shane D., Chen-Hardee, Shari S.

“…Objective. To estimate the average survival effects of breast conserving surgery plus irradiation relative to mastectomy for marginal stage II breast cancer…”
Get full text

Factors associated with early termination of CHOP therapy and the impact on survival among patients with chemosensitive intermediate-grade non-Hodgkin's lymphoma by Chrischilles, Elizabeth A, Link, Brian K, Scott, Shane D, Delgado, David J, Fridman, Moshe

“…Six to eight cycles of CHOP therapy (cyclophosphamide, doxorubicin, vincristine, and prednisone) is standard for intermediate-grade non-Hodgkin's lymphoma…”
Get more information

Managing Anemia in Patients with Chronic Kidney Disease or Cancer: Development and Role of Darbepoetin alfa by Scott, Shane D.

Get full text

Anticholinergic agents for the treatment of “death rattle” in patients with myasthenia gravis by Spiess, Jeffrey L., Scott, Shane D.

“…Difficulty clearing upper airway secretions (death rattle) is a frequent problem at the end of life. Treatment often includes the use of anticholinergic drugs…”
Get full text

Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma by Scott, S D

“…Rituximab is an effective single agent available for short-course outpatient treatment in low-grade NHL, particularly with follicular histology (IWF B-D), that…”
Get more information

Effect of Clinical Characteristics on Neutropenia‐Related Inpatient Costs Among Newly Diagnosed Non‐Hodgkin's Lymphoma Cases During First‐Course Chemotherapy by Chrischilles, Elizabeth A., Klepser, Donald G., Brooks, John M., Voelker, Margaret D., Chen‐Hardee, Shari S., Scott, Shane D., Link, Brian K., Delgado, David J.

“…Study Objective. To estimate the costs of hospitalization for neutropenia among chemotherapy‐treated patients with newly diagnosed non‐Hodgkin's lymphoma and…”
Get full text

Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone by Perry, Paul J, MacIndoe, John H, Yates, William R, Scott, Shane D, Holman, Timothy L

“…Our goal in this study was to determine whether the urinary ratio of testosterone to luteinizing hormone (T/LH) as an indicator of exogenous anabolic steroid…”
Get full text

Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapy by Scott, Shane D, Chrischilles, Elizabeth A, Link, Brian K, Delgado, David J, Fridman, Moshe, Stolshek, Bradley S

“…Filgrastim prophylaxis lessens the occurrence of febrile neutropenia in patients with non-Hodgkin.s lymphoma (NHL) treated with chemotherapy, but differences…”
Get full text

Dose conversion from recombinant human erythropoietin to darbepoetin alfa: Recommendations from clinical studies: Managing anemia in patients with chronic kidney disease or cancer: development and role of darbepoetin alfa by SCOTT, Shane D

Get full text

Time to Take Stock and Evaluate by Scott, Shane D

Get full text

Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation by Lee, Choon-Kee, Gingrich, Roger D, deMagalhaes-Silverman, Margarida, Hohl, Raymond J, Joyce, Jacqueline K, Scott, Shane D, Wen, B-Chen, Schlueter, Annette

“…To increase the graft-vs.-leukemia (GVL) effect while maintaining a low mortality from graft-vs.-host disease (GVHD), we conducted a prospective study of T…”
Get full text

Testosterone suppression of the HPT axis by MacIndoe, J H, Perry, P J, Yates, W R, Holman, T L, Ellingrod, V L, Scott, S D

“…Although studies have demonstrated the suppression of normal gonadal function in the experimental setting, the specific mechanisms by which androgenic-anabolic…”
Get full text

In Reply by Scott, Shane D

Get full text

In Reply by Scott, Shane D

Get full text

Pharmaceutical Care, Specialisation and Certification by Scott, Shane D.

Get full text

Continuous subcutaneous heparin infusion for treatment of Trousseau's syndrome by Alderman, C P, McClure, A F, Jersmann, H P, Scott, S D

“…To describe the use of continuous subcutaneous heparin infusion in the treatment of 2 cases of Trousseau's syndrome. Two patients with metastatic carcinoma…”
Get more information

Toxicity potential of oral lidocaine in a patient receiving mexiletine by Geraets, D R, Scott, S D, Ballew, K A

“…To report a case of toxicity from orally administered lidocaine in a patient with cardiomyopathy receiving concurrent mexiletine therapy. Case reports, review…”
Get more information

Pharmacoeconomics and Considerations for Injectable Products: Focus on Colony-Stimulating Factors by Chrischilles, Elizabeth A., Cosler, Leon E., Delgado, David J., Link, Brian K., Fridman, Moshe, Mucenski, John W., Scott, Shane D., Semroc, Georgette N., Shogan, Jeffrey E., Stolshek, Bradley S., Tierce, Jonothan C.

Get full text